Jérusalem

The Challenging Face of Jerusalem’s Haredi Population: Opportunities for the Future

Retrieved on: 
Thursday, November 21, 2019
Geography of Asia, Western Asia, Jerusalem Governorate, East Jerusalem, Jerusalem District, Jérusalem, Israel

Keynote speakers at the event were Shai Doron, President, The Jerusalem Foundation, andIsrael Kellerman, Deputy Mayor of Jerusalem.

Key Points: 
  • Keynote speakers at the event were Shai Doron, President, The Jerusalem Foundation, andIsrael Kellerman, Deputy Mayor of Jerusalem.
  • Simmy Zieleniec, CEO, Canadian Friends of Jerusalem College of Technology gave closing remarks, Jerusalem based Nomi Yeshua, Chief Development Officer, The Jerusalem Foundation, was a special guest.
  • Robin Gofine, in her kick off to the evenings program, expressed the importance of the close relationship between the Jerusalem College of Technology and The Jerusalem Foundation.
  • www.cfjct.org
    The Jerusalem Foundation: The Jerusalem Foundation has been working on behalf of Jerusalem and its residents for more than 50 years.

Entera Bio Reports Third Quarter 2019 Financial Results and Provides Operating Update

Retrieved on: 
Thursday, November 21, 2019
Distributed computing, Entera, Middleware, Partnering, NASDAQ, Amgen, Economy of the United States, Companies, Life sciences

BOSTONand JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today provided a corporate update and reported financial results for the third quarter ended September30, 2019.

Key Points: 
  • BOSTONand JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today provided a corporate update and reported financial results for the third quarter ended September30, 2019.
  • Our ongoing business development and collaboration discussions are also advancing across all three pillars of our partnering strategy.
  • Further, we are building our financial, business development and investor focused teams and strategies to elevate Enteras profile with the investment and partnering community.
  • Revenues for the nine months ended September 30, 2019 were $134 thousand from services provided to Amgen under the license agreement.

Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer

Retrieved on: 
Thursday, November 21, 2019
Distributed computing, Entera, Middleware, USS Gridley

BOSTON and JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today announced that it has established a U.S. Headquarters in the Boston area and has hired Jonathan Lieber as its U.S.-based CFO.

Key Points: 
  • BOSTON and JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today announced that it has established a U.S. Headquarters in the Boston area and has hired Jonathan Lieber as its U.S.-based CFO.
  • We are pleased to have an accomplished executive of Jons caliber join Entera Bio.
  • We welcome his long experience at emerging life science companies and his strong investor and banking relationships, stated Adam Gridley, CEO of Entera.
  • Entera Bio Inc., the Company's wholly owned Delaware subsidiary, established its U.S. Headquarters in the Boston area (Wellesley, Mass) to support the Companys future growth in financial, business development and clinical / regulatory staff.

BrainsWay to Report Third Quarter 2019 Financial Results on November 25, 2019

Retrieved on: 
Thursday, November 14, 2019
Neuroscience, Branches of biology, Brainsway, Neurophysiology, Neuropsychology, Neurotechnology, Treatment of depression, Forward-looking statement, Tel Aviv Stock Exchange, Medicine, GlobeNewswire, NASDAQ

JERUSALEM and HACKENSACK, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it will report its third quarter 2019 financial results before the opening of the U.S. financial markets on Monday, November 25, 2019.

Key Points: 
  • JERUSALEM and HACKENSACK, N.J., Nov. 14, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it will report its third quarter 2019 financial results before the opening of the U.S. financial markets on Monday, November 25, 2019.
  • The company will host a conference call at 9:00 AM Eastern Time to review the financial results and operational highlights.
  • This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
  • Any forward-looking statement in this press release speaks only as of the date of this press release.

Entera Bio to Announce Third Quarter 2019 Financial Results on Thursday, November 21, 2019

Retrieved on: 
Thursday, November 7, 2019
Communication, Forward-looking statement, Security

Entera has developed a proprietary platform technology that enables oral delivery of biologicals and large molecule drugs, which are typically delivered via injections and or other non-oral pathways.

Key Points: 
  • Entera has developed a proprietary platform technology that enables oral delivery of biologicals and large molecule drugs, which are typically delivered via injections and or other non-oral pathways.
  • This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995.
  • Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov .
  • The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Mobileye Outlines Strategy for Driving Significant Growth

Retrieved on: 
Tuesday, November 5, 2019
Semiconductor, Aftermarket, Automotive, Automotive Manufacturing, Technology, Manufacturing, Hardware, Companies, Technology, Artificial intelligence, Self-driving cars, Mobileye, Amnon Shashua, Intel, Jérusalem, Amnon

During an investor summit today at Mobileye headquarters in Jerusalem, Mobileye President and CEO Professor Amnon Shashua projected significant and sustained revenue growth for the next decade.

Key Points: 
  • During an investor summit today at Mobileye headquarters in Jerusalem, Mobileye President and CEO Professor Amnon Shashua projected significant and sustained revenue growth for the next decade.
  • At the event, Intel CFO George Davis described Mobileye as one of the companys strategic, data-centric growth opportunities, which is outperforming Intels initial expectations.
  • View the full release here: https://www.businesswire.com/news/home/20191105005383/en/
    During an investor summit at Mobileye headquarters in Jerusalem on Tuesday, Nov. 5, 2019, Mobileye President and CEO Professor Amnon Shashua projected significant and sustained revenue growth for the next decade.
  • In the 2019's third quarter , Mobileye achieved another record quarter with 20 percent revenue growth year over year driven by continued advanced driver-assistance systems (ADAS) momentum.

Largest International Technology Transfer Conference Underscores Leadership of Local Institutions

Retrieved on: 
Monday, November 4, 2019
Geography of Asia, Geography of religion, Cities in Asia, Intellectual property law, Knowledge transfer, Technology transfer, Association of University Technology Managers, Hebrew University of Jerusalem, Ofra, Jérusalem, Weinberger

JERUSALEM, Nov. 4, 2019 /PRNewswire/ -- The largest international technology transfer conference, AUTM ASIA, will take place for the first time in Israel, hosted this week by Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem now celebrating its 55th year.

Key Points: 
  • JERUSALEM, Nov. 4, 2019 /PRNewswire/ -- The largest international technology transfer conference, AUTM ASIA, will take place for the first time in Israel, hosted this week by Yissum, the Technology Transfer Company of The Hebrew University of Jerusalem now celebrating its 55th year.
  • This year's conference willshowcase powerful stories at the intersection of invention, innovation and commercialization to provide valuable expertise and know-how to navigate the next era of tech transfer.
  • Featured speakers at the conference, held at Jerusalem's Ramada Hotel, include:
    Dr. Ofra Weinberger, PhD, Director, Licensing & Commercialization, Columbia Technology Ventures and Assoc.
  • Highlights of the three-day conference include:
    The Hackathon: Tues, Nov 5:Brainstorming New Models for Inter-Institutional and International Knowledge-based Collaborations.

A Stepping Stone Hosts Open House to Introduce Newly Offered FDA-Cleared Helmet to Treat Major Depressive Disorder (MDD)

Retrieved on: 
Tuesday, October 29, 2019
Neuroscience, Branches of biology, Psychiatry, Neurotechnology, Treatment of depression, Neurophysiology, Neuropsychology, Treatment of bipolar disorder, Transcranial magnetic stimulation, Brainsway, Mental health

We focus on individualizing each patients treatment and believe that there is no one size fits all option for mental health.

Key Points: 
  • We focus on individualizing each patients treatment and believe that there is no one size fits all option for mental health.
  • For the patients who identify as treatment-resistant, Deep TMS provides an alternative option and could be the answer that they have longed for.
  • BrainsWays Deep TMS administers magnetic waves through a cushioned helmet to target deep structures of the brain that impact a patients MDD symptoms.
  • A Stepping Stone provides experienced, holistic, integrated and comprehensive mental health and substance abuse treatments.

BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting

Retrieved on: 
Tuesday, October 1, 2019
Neuroscience, Branches of biology, Neurophysiology, Neuropsychology, Neurotechnology, Treatment of depression, Brainsway, Forward-looking statement, Propel, Medicine

BrainsWay is also exhibiting at the conference and offering hands-on demonstrations of the dTMS device, allowing physicians to experience first-hand how the device can easily and seamlessly be integrated into their practice.

Key Points: 
  • BrainsWay is also exhibiting at the conference and offering hands-on demonstrations of the dTMS device, allowing physicians to experience first-hand how the device can easily and seamlessly be integrated into their practice.
  • This years Psych Congress provides BrainsWay an excellent setting to showcase our innovative dTMS technology and recent results from the landmark European study, which continues to propel us forward, said David Zacut, MD, founder and chairman of the board of BrainsWay.
  • Any forward-looking statement in this press release speaks only as of the date of this press release.
  • More detailed information about the risks and uncertainties affecting the Company is contained under the heading Risk Factors in the Companys filings with the U.S. Securities and Exchange Commission.

Achieve TMS East Celebrates the Opening of a New Office in West Hartford, Connecticut

Retrieved on: 
Tuesday, September 24, 2019
Greater Hartford, Neuroscience, Branches of biology, Brainsway, Neurophysiology, Neuropsychology, Neurotechnology, Treatment of depression, TMS, West Hartford, Connecticut, Hartford, Connecticut, Medicine

Among the distinguished guests will be Achieve TMS Easts West Hartford psychiatrist, Dr. Pamela Kurth, Achieve TMS Easts Director of Operations, Marjorie Pierce and members of the West Hartford Chamber of Commerce.

Key Points: 
  • Among the distinguished guests will be Achieve TMS Easts West Hartford psychiatrist, Dr. Pamela Kurth, Achieve TMS Easts Director of Operations, Marjorie Pierce and members of the West Hartford Chamber of Commerce.
  • Following the grand opening Achieve TMS East will be hosting public open houses once a month in the West Hartford office.
  • Achieve TMS East, with 16 locations, is the largest provider of BrainsWays Deep TMS in New England.
  • Achieve TMS East opened its first deep TMS clinic in December of 2016 in Northampton, MA and today has 16 clinics.